ciprofloxacin has been researched along with Acute Kidney Failure in 55 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of acute interstitial nephritis confirmed by renal biopsy that developed in a patient within days of starting ciprofloxacin therapy." | 8.78 | Ciprofloxacin-induced acute interstitial nephritis. ( Bailey, JR; Philbrick, JT; Trott, SA, 1992) |
| " We present a 56-year-old man with a history of hypertension, chronic kidney disease stage IIIa, recent exposure to ciprofloxacin who presented with acute kidney injury." | 8.02 | Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin. ( Jim, B; Saad, P; Sekulic, M; Valdez Imbert, R, 2021) |
| "Rhabdomyolysis is one of the serious side effects of ciprofloxacin (CPFX), a widely used antibacterial drug; and occasionally, acute kidney injury (AKI) occurs." | 7.88 | Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. ( Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T, 2018) |
| "We report a case of ciprofloxacin-induced acute non-oliguric renal failure that developed in a patient with chronic glomerulonephritis." | 7.73 | [Ciprofloxacin-induced acute non-oliguric renal failure in patient with chronic glomerulonephritis]. ( Czekalski, S; Niemir, ZI; Nowak, A; Paszkowska, M, 2005) |
| " We report an 18-year-old young woman with cystic fibrosis who experienced a pronounced decline in renal function after oral treatment with ciprofloxacin for 3 weeks." | 7.71 | Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. ( Bald, M; Nikolaizik, W; Ratjen, F; Wingen, AM, 2001) |
| "Cefepime therapy was ceased and treatment with ciprofloxacin was given to complete the treatment course." | 5.42 | Cefepime induced acute interstitial nephritis--a case report. ( Chavada, R; Howlin, K; Mac, K; Paull, S; Wong, J, 2015) |
| "Acute renal insufficiency is known to occur in patients who are taking ciprofloxacin, particularly the elderly." | 5.32 | Ciprofloxacin-induced renal insufficiency in cystic fibrosis. ( Moffett, BS; Mogayzel, PJ; Rosenstein, BJ, 2003) |
| " In all critically ill patients ciprofloxacin elimination was significantly slowed; the mean half-life was similarly prolonged to about 14 h in patients on haemofiltration and those with approximately normal renal function." | 5.31 | Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. ( Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Egger, P; Gritsch, W; Joannidis, M; Wiedermann, ChJ, 2002) |
| "He developed non-oliguric acute renal failure that was treated successfully." | 5.28 | Typhoid fever, ciprofloxacin, and renal failure. ( Dodd, K; Mellersh, A; Nelson, CS; Simpson, J; Watson, AR, 1991) |
| " We report a case of acute interstitial nephritis confirmed by renal biopsy that developed in a patient within days of starting ciprofloxacin therapy." | 4.78 | Ciprofloxacin-induced acute interstitial nephritis. ( Bailey, JR; Philbrick, JT; Trott, SA, 1992) |
| " Spironolactone, furosemide, and trimethoprim with sulfamethoxazole are medicines that, in particular, need to be used carefully and monitored closely in patients in the community at risk of acute kidney injury." | 4.12 | Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care. ( Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE, 2022) |
| " We present a 56-year-old man with a history of hypertension, chronic kidney disease stage IIIa, recent exposure to ciprofloxacin who presented with acute kidney injury." | 4.02 | Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin. ( Jim, B; Saad, P; Sekulic, M; Valdez Imbert, R, 2021) |
| "Rhabdomyolysis is one of the serious side effects of ciprofloxacin (CPFX), a widely used antibacterial drug; and occasionally, acute kidney injury (AKI) occurs." | 3.88 | Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. ( Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T, 2018) |
| "Twenty-four critically ill adult patients with acute kidney injury receiving ciprofloxacin, meropenem, piperacillin/tazobactam, or vancomycin during continuous renal replacement therapy." | 3.78 | Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. ( Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS, 2012) |
| "We report a case of ciprofloxacin-induced acute non-oliguric renal failure that developed in a patient with chronic glomerulonephritis." | 3.73 | [Ciprofloxacin-induced acute non-oliguric renal failure in patient with chronic glomerulonephritis]. ( Czekalski, S; Niemir, ZI; Nowak, A; Paszkowska, M, 2005) |
| " We report an 18-year-old young woman with cystic fibrosis who experienced a pronounced decline in renal function after oral treatment with ciprofloxacin for 3 weeks." | 3.71 | Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. ( Bald, M; Nikolaizik, W; Ratjen, F; Wingen, AM, 2001) |
| "We report a case of ciprofloxacin-related allergic tubulointerstitial nephritis, which manifested as nonoliguric renal failure, eosinophilia, and eosinophiluria." | 3.68 | Allergic nephropathy associated with ciprofloxacin. ( Atkinson, JL; McCarthy, JT; Rastogi, S, 1990) |
| "Six critically ill patients with acute renal failure on CVVHDF." | 2.70 | Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration. ( Daley, PJ; Lipman, J; Mullany, DV; Rickard, CM; Wallis, SC, 2001) |
| "We studied the pharmacokinetic and clearance of a 200 mg ciprofloxacin and a 500 mg amikacin intravenous dose during 5 continuous hemodialysis procedures in 5 patients with acute oliguric renal failure." | 2.68 | [Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis]. ( Aguila, R; Cotera, A; Gaete, L; Lorca, E; Saffie, A; Thambo, S, 1995) |
| "A 58 year-old woman developed an acute renal failure very quickly after ingestion of two 500 mg tablets of ciprofloxacin, without any other identifiable risk factor." | 2.43 | [Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin]. ( Birembaut, P; Briat, C; Daudon, M; Montagnac, R; Sartelet, H; Schillinger, F, 2005) |
| "We investigated the production of toxic shock syndrome toxin 1 (TSST-1) and staphylococcal enterotoxins (SE)." | 2.39 | [A case of toxic shock syndrome (TSS) induced by methicillin-resistant staphylococcus aureus (MRSA) presenting as acute renal failure with disseminated intravascular coagulation]. ( Fujimoto, Y; Fukuuchi, F; Hida, M; Hiraga, S; Satoh, T, 1996) |
| "We report three cases of acute renal failure following ciprofloxacin in patients without a previous history of renal insufficiency." | 2.38 | Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. ( Fenves, AZ; Hootkins, R; Stephens, MK, 1989) |
| "Five patients with cancer who developed acute renal failure that followed treatment with ciprofloxacin are described and an additional 15 cases reported in the literature are reviewed." | 2.38 | Ciprofloxacin-induced nephrotoxicity in patients with cancer. ( Bodey, GP; Lo, WK; Rolston, KV; Rubenstein, EB, 1993) |
| "Acute kidney injury is very common in hospitalized patients and has been described in up to twenty percent of admissions." | 1.72 | [Antibiotic-induced acute kidney injury]. ( Brand, EC; Kers, JF; Molenaar, FM; Oosterheert, JJ; Vissers, LATM, 2022) |
| "Cefepime therapy was ceased and treatment with ciprofloxacin was given to complete the treatment course." | 1.42 | Cefepime induced acute interstitial nephritis--a case report. ( Chavada, R; Howlin, K; Mac, K; Paull, S; Wong, J, 2015) |
| "Ciprofloxacin is a widely used fluoroquinolone for the treatment of patients with complicated and uncomplicated infections." | 1.34 | Ciprofloxacin crystal nephropathy. ( Bozzola, C; Canavese, C; Lazzarich, E; Monga, G; Stratta, P, 2007) |
| "Acute renal insufficiency is known to occur in patients who are taking ciprofloxacin, particularly the elderly." | 1.32 | Ciprofloxacin-induced renal insufficiency in cystic fibrosis. ( Moffett, BS; Mogayzel, PJ; Rosenstein, BJ, 2003) |
| "Rhabdomyolysis and acute renal failure were successfully treated by transfusion, diuretic therapy, and glucocorticoid therapy." | 1.32 | [Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis]. ( Kawai, A; Nakajima, H; Nakajima, S; Sawaguchi, H; Touda, Y, 2004) |
| "The bioavailability of grepafloxacin in ARF rats was 1." | 1.32 | Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats. ( Inui, K; Saito, H; Yamaguchi, H; Yano, I, 2004) |
| " In all critically ill patients ciprofloxacin elimination was significantly slowed; the mean half-life was similarly prolonged to about 14 h in patients on haemofiltration and those with approximately normal renal function." | 1.31 | Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. ( Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Egger, P; Gritsch, W; Joannidis, M; Wiedermann, ChJ, 2002) |
| " The dosing regimen of each drug that yielded serum levels in mice which mimic human therapeutic concentrations of the drugs, were designed." | 1.30 | Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. ( Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Owens, RC; Quintiliani, R, 1999) |
| "We investigated the effect of acute renal failure on the neurotoxicity of enoxacin (ENX) in rats." | 1.30 | Effect of acute renal failure on neurotoxicity of enoxacin in rats. ( Iga, T; Kawakami, J; Ohashi, K; Sawada, Y; Yamamoto, K, 1997) |
| "For vancomycin, Vdarea was 60." | 1.28 | Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis. ( Azadian, BS; Brown, EA; Davies, SP; Kox, WJ, 1992) |
| "Renal parenchymal malacoplakia is a rare cause of renal failure." | 1.28 | Renal malacoplakia with papillary necrosis and renal failure. ( Kohn, OF; Mokrzycki, MH; Yamase, H, 1992) |
| "He developed non-oliguric acute renal failure that was treated successfully." | 1.28 | Typhoid fever, ciprofloxacin, and renal failure. ( Dodd, K; Mellersh, A; Nelson, CS; Simpson, J; Watson, AR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (12.73) | 18.7374 |
| 1990's | 26 (47.27) | 18.2507 |
| 2000's | 12 (21.82) | 29.6817 |
| 2010's | 6 (10.91) | 24.3611 |
| 2020's | 4 (7.27) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, H | 1 |
| Yano, I | 1 |
| Saito, H | 1 |
| Inui, K | 1 |
| Roughead, EE | 1 |
| Kerr, M | 1 |
| Moffat, A | 1 |
| Kassie, GM | 1 |
| Pratt, N | 1 |
| Vissers, LATM | 1 |
| Brand, EC | 1 |
| Kers, JF | 1 |
| Molenaar, FM | 1 |
| Oosterheert, JJ | 1 |
| Martin, M | 1 |
| Boixeda, R | 1 |
| Muñoz, A | 1 |
| Felip, À | 1 |
| Valdez Imbert, R | 1 |
| Sekulic, M | 1 |
| Saad, P | 1 |
| Jim, B | 1 |
| Matsubara, A | 1 |
| Oda, S | 1 |
| Akai, S | 1 |
| Tsuneyama, K | 1 |
| Yokoi, T | 1 |
| Mac, K | 1 |
| Chavada, R | 1 |
| Paull, S | 1 |
| Howlin, K | 1 |
| Wong, J | 1 |
| Gagneux-Brunon, A | 1 |
| Pillet, S | 1 |
| Laurent, B | 1 |
| Mariat, C | 1 |
| Michalet, M | 1 |
| Lucht, F | 1 |
| Botelho-Nevers, E | 1 |
| Friedl, C | 1 |
| Hackl, G | 1 |
| Schilcher, G | 1 |
| Rosenkranz, AR | 1 |
| Eller, K | 1 |
| Eller, P | 1 |
| Dichiara, AJ | 1 |
| Atkinson, M | 1 |
| Goodman, Z | 1 |
| Sherman, KE | 1 |
| Qian, Q | 1 |
| Nasr, SH | 1 |
| Akogyeram, CO | 1 |
| Sethi, S | 1 |
| Roberts, DM | 1 |
| Roberts, JA | 1 |
| Roberts, MS | 1 |
| Liu, X | 1 |
| Nair, P | 1 |
| Cole, L | 1 |
| Lipman, J | 2 |
| Bellomo, R | 1 |
| Bellmann, R | 1 |
| Egger, P | 1 |
| Gritsch, W | 1 |
| Bellmann-Weiler, R | 1 |
| Joannidis, M | 1 |
| Dunzendorfer, S | 1 |
| Wiedermann, ChJ | 1 |
| Kawai, A | 1 |
| Nakajima, H | 1 |
| Sawaguchi, H | 1 |
| Touda, Y | 1 |
| Nakajima, S | 1 |
| Moffett, BS | 1 |
| Rosenstein, BJ | 1 |
| Mogayzel, PJ | 1 |
| Paszkowska, M | 1 |
| Niemir, ZI | 1 |
| Nowak, A | 1 |
| Czekalski, S | 1 |
| Sedlacek, M | 1 |
| Suriawinata, AA | 1 |
| Schoolwerth, A | 1 |
| Remillard, BD | 1 |
| Montagnac, R | 1 |
| Briat, C | 1 |
| Schillinger, F | 1 |
| Sartelet, H | 1 |
| Birembaut, P | 1 |
| Daudon, M | 1 |
| Stratta, P | 1 |
| Lazzarich, E | 1 |
| Canavese, C | 1 |
| Bozzola, C | 1 |
| Monga, G | 1 |
| Yew, WW | 1 |
| Chau, CH | 1 |
| Wong, PC | 1 |
| Choi, HY | 1 |
| Lucena, MI | 1 |
| Marquez, M | 1 |
| Velasco, JL | 1 |
| Andrade, RJ | 1 |
| Connor, JP | 1 |
| Curry, JM | 1 |
| Selby, TL | 1 |
| Perlmutter, AD | 1 |
| Rosado, LJ | 1 |
| Siskind, MS | 1 |
| Copeland, JG | 1 |
| Anand, A | 1 |
| Lo, WK | 1 |
| Rolston, KV | 1 |
| Rubenstein, EB | 1 |
| Bodey, GP | 1 |
| Cotera, A | 1 |
| Aguila, R | 1 |
| Gaete, L | 1 |
| Saffie, A | 1 |
| Lorca, E | 1 |
| Thambo, S | 1 |
| Fukuuchi, F | 1 |
| Hida, M | 1 |
| Fujimoto, Y | 1 |
| Hiraga, S | 1 |
| Satoh, T | 1 |
| Kawakami, J | 1 |
| Ohashi, K | 1 |
| Yamamoto, K | 1 |
| Sawada, Y | 1 |
| Iga, T | 1 |
| Dharnidharka, VR | 1 |
| Nadeau, K | 1 |
| Cannon, CL | 1 |
| Harris, HW | 1 |
| Rosen, S | 1 |
| Raja, N | 1 |
| Miller, WE | 1 |
| McMillan, R | 1 |
| Mason, JR | 1 |
| Onyeji, CO | 1 |
| Bui, KQ | 1 |
| Owens, RC | 1 |
| Nicolau, DP | 1 |
| Quintiliani, R | 1 |
| Nightingale, CH | 1 |
| Bhowmik, D | 1 |
| Dash, SC | 1 |
| Dinda, AK | 1 |
| Tiwari, SC | 1 |
| Agarwal, SK | 1 |
| Gupta, S | 1 |
| Mathur, RP | 1 |
| Bald, M | 1 |
| Ratjen, F | 1 |
| Nikolaizik, W | 1 |
| Wingen, AM | 1 |
| Kroh, UF | 1 |
| Wallis, SC | 1 |
| Mullany, DV | 1 |
| Rickard, CM | 1 |
| Daley, PJ | 1 |
| Davies, SP | 1 |
| Azadian, BS | 1 |
| Kox, WJ | 1 |
| Brown, EA | 1 |
| Barrie, JR | 1 |
| Mousdale, S | 1 |
| Bailey, JR | 1 |
| Trott, SA | 1 |
| Philbrick, JT | 1 |
| Mokrzycki, MH | 1 |
| Yamase, H | 1 |
| Kohn, OF | 1 |
| Arvieux, C | 2 |
| Charasse, C | 2 |
| Guilhem, I | 2 |
| Rivalan, J | 2 |
| Le Pogamp, P | 2 |
| Ramée, MP | 2 |
| Simpson, J | 1 |
| Watson, AR | 1 |
| Mellersh, A | 1 |
| Nelson, CS | 1 |
| Dodd, K | 1 |
| George, MJ | 1 |
| Dew, RB | 1 |
| Daly, JS | 1 |
| Andersen, I | 1 |
| Sjöström, P | 1 |
| Gonski, PN | 1 |
| Allon, M | 1 |
| Lopez, EJ | 1 |
| Min, KW | 1 |
| Hatton, J | 1 |
| Haagensen, D | 1 |
| Rastogi, S | 1 |
| Atkinson, JL | 1 |
| McCarthy, JT | 1 |
| Hootkins, R | 1 |
| Fenves, AZ | 1 |
| Stephens, MK | 1 |
| Lee, CW | 1 |
| Fialkow, RZ | 1 |
| Van Wyck, D | 1 |
| Dirksen, MS | 1 |
| Vree, TB | 1 |
| Avent, CK | 1 |
| Krinsky, D | 1 |
| Kirklin, JK | 1 |
| Bourge, RC | 1 |
| Figg, WD | 1 |
| Gerritsen, WR | 1 |
| Peters, A | 1 |
| Henny, FC | 1 |
| Brouwers, JR | 1 |
| Rippelmeyer, DJ | 1 |
| Synhavsky, A | 1 |
| Dibble, JB | 1 |
| Acomb, C | 1 |
| Campbell, L | 1 |
| White, LO | 1 |
| Brownjohn, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy[NCT04282785] | 100 participants (Anticipated) | Observational | 2019-04-26 | Active, not recruiting | |||
| Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)[NCT04033029] | 20 participants (Actual) | Observational | 2021-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for ciprofloxacin and Acute Kidney Failure
| Article | Year |
|---|---|
Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ciprofloxacin; | 2017 |
Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Cellulitis; Cholestasis; Ciprofloxacin; Humans; Ja | 2008 |
[Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin].
Topics: Acute Kidney Injury; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Kidney; | 2005 |
Acute renal failure secondary to ciprofloxacin use.
Topics: Acute Kidney Injury; Adult; Ciprofloxacin; Female; Humans | 1994 |
Ciprofloxacin-induced nephrotoxicity in patients with cancer.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Female; Fever; Humans; Kidney; Male; Middle Aged; Neoplasm | 1993 |
[A case of toxic shock syndrome (TSS) induced by methicillin-resistant staphylococcus aureus (MRSA) presenting as acute renal failure with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Bacterial Toxins; Cip | 1996 |
Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes.
Topics: Acute Kidney Injury; Adolescent; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Ap | 1998 |
Ciprofloxacin-induced acute interstitial nephritis.
Topics: Acute Kidney Injury; Aged; Bronchitis; Ciprofloxacin; Female; Humans; Nephritis, Interstitial | 1992 |
[Acute renal insufficiency caused by tubulo-interstitial nephropathy after treatment with ciprofloxacin].
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Humans; Male; Nephritis, Interstitial | 1991 |
Acute renal failure due to ciprofloxacin.
Topics: Acute Kidney Injury; Adult; Aged; Biopsy; Ciprofloxacin; Erythema Multiforme; Female; Humans; Kidney | 1990 |
Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Ciprofloxacin; Female; Humans; Middle Aged | 1989 |
2 trials available for ciprofloxacin and Acute Kidney Failure
| Article | Year |
|---|---|
[Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis].
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood Proteins; Ciprofl | 1995 |
Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; He | 2001 |
42 other studies available for ciprofloxacin and Acute Kidney Failure
| Article | Year |
|---|---|
Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Antineoplastic Agents; Bile Ducts; Biological A | 2004 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; | 2022 |
[Antibiotic-induced acute kidney injury].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Ciprofloxacin; Humans; Kidney; Nephritis, Interstitial | 2022 |
Ciprofloxacin as a cause of acute renal failure.
Topics: Acute Kidney Injury; Ciprofloxacin; Humans | 2020 |
Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin.
Topics: Acute Kidney Injury; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Humans; Male; M | 2021 |
Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Atorvastatin; Buth | 2018 |
Cefepime induced acute interstitial nephritis--a case report.
Topics: Acute Kidney Injury; Cefepime; Cephalosporins; Ciprofloxacin; Escherichia coli Infections; Female; H | 2015 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplant | 2015 |
Myoglobin-associated acute kidney injury in the setting of ciprofloxacin administration.
Topics: Acute Kidney Injury; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Middle Aged; Myoglobin | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltr | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltr | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltr | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltr | 2012 |
Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.
Topics: Acute Kidney Injury; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; | 2002 |
[Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibodies, Bacterial; Antigens; Antigens, Bacteri | 2004 |
Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Infective Agents; Blood Urea Nitrogen; Ciprofloxacin; C | 2003 |
[Ciprofloxacin-induced acute non-oliguric renal failure in patient with chronic glomerulonephritis].
Topics: Acute Kidney Injury; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Glomerulo | 2005 |
Ciprofloxacin crystal nephropathy--a 'new' cause of acute renal failure.
Topics: Acute Kidney Injury; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Crystallization; Duode | 2006 |
Ciprofloxacin crystal nephropathy.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Crystallization; Female; Humans; Male; Risk Factors | 2007 |
Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Female; Humans; Male; Mycobacterium Infections, Nontubercu | 1995 |
Acute renal failure attributable to ciprofloxacin in a patient with the acquired immunodeficiency syndrome.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Humans; Male; Pneu | 1995 |
Acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin.
Topics: Acute Kidney Injury; Ciprofloxacin; Heart Transplantation; Humans; Immunosuppression Therapy; Male; | 1994 |
Ciprofloxacin nephrotoxicity.
Topics: Acute Kidney Injury; Aged; Aging; Ciprofloxacin; Humans | 1993 |
Effect of acute renal failure on neurotoxicity of enoxacin in rats.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Brain; Chromatography, High Pressure Liquid; Ci | 1997 |
Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue.
Topics: Acute Kidney Injury; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Ciproflo | 1998 |
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.
Topics: Acute Kidney Injury; Administration, Cutaneous; Animals; Anti-Infective Agents; Bacteremia; Ciproflo | 1999 |
Recurrent granulomatous acute interstitial nephritis induced by commonly used antibiotics.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dexamethaso | 1999 |
Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Anti-Infective Agents; Ciprofloxacin; Creatinine; Cystic Fibrosis; | 2001 |
Pharmacokinetic studies in patients on continuous renal replacement therapies.
Topics: Acute Kidney Injury; Anti-Infective Agents; Ciprofloxacin; Humans; Intensive Care Units; Renal Repla | 2001 |
Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Ciprofloxacin; Female; Humans; Male; Metabolic Clearance Rate; Mid | 1992 |
Ciprofloxacin levels in a patient undergoing veno-venous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Chromatography, High Pressure Liquid; Ciprofloxacin; Dialysis Solutions; | 1992 |
Renal malacoplakia with papillary necrosis and renal failure.
Topics: Acute Kidney Injury; Alcoholism; Ciprofloxacin; Humans; Kidney Diseases; Kidney Papillary Necrosis; | 1992 |
[Acute kidney failure due to tubulo-interstitial nephropathy after treatment with ciprofloxacin].
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Humans; Lung Diseases; Male | 1991 |
Typhoid fever, ciprofloxacin, and renal failure.
Topics: Acute Kidney Injury; Child; Ciprofloxacin; Humans; Kidney; Male; Typhoid Fever | 1991 |
Acute renal failure after an overdose of ciprofloxacin.
Topics: Acute Kidney Injury; Adult; Ciprofloxacin; Drug Overdose; Female; Humans | 1991 |
[Ciprofloxacin can cause allergic interstitial nephritis with acute renal failure].
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Nephritis, Intersti | 1991 |
Ciprofloxacin-induced renal failure in an elderly patient.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans | 1991 |
Renal dysfunction associated with ciprofloxacin.
Topics: Acute Kidney Injury; Ciprofloxacin; Creatinine; Female; Gentamicins; Humans; Kidney Concentrating Ab | 1990 |
Allergic nephropathy associated with ciprofloxacin.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Drug Hypersensitivity; Eosinophilia; Humans; Male; Nephrit | 1990 |
Adverse effects associated with the newer fluoroquinolones.
Topics: Acute Kidney Injury; Ciprofloxacin; Humans; Liver Diseases, Alcoholic; Male; Middle Aged | 1989 |
Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Ciprofloxacin; Creatinine; Critical Care; Female; Half-Life; Human | 1986 |
Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine.
Topics: Acute Kidney Injury; Ciprofloxacin; Cyclosporins; Drug Synergism; Heart Transplantation; Humans; Imm | 1988 |
Ciprofloxacin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Ciprofloxacin; Female; Humans | 1987 |
Ciprofloxacin and allergic interstitial nephritis.
Topics: Acute Kidney Injury; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Middle Aged; Nephritis, I | 1988 |
Dosage of intravenous ciprofloxacin.
Topics: Acute Kidney Injury; Adult; Ciprofloxacin; Humans; Injections, Intravenous; Male; Pseudomonas Infect | 1987 |